XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 04, 2022
Apr. 01, 2022
May 04, 2020
May 04, 2020
Oct. 01, 2019
Jul. 07, 2019
Aug. 27, 2018
Apr. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jul. 31, 2022
Feb. 11, 2021
Loss Contingencies [Line Items]                              
Annual royalty obligation                       $ 201,000      
Royalty expense                       $ 812,966 $ 404,220    
Royalty percentage                       2.00%      
Maximum amount of royalty                             $ 800,000
Royalty payments                 $ 50,250     $ 201,000      
Cash     $ 500,000 $ 500,000                      
Annual royalty obligation                 4,020     $ 16,080      
Cash consideration $ 125,966 $ 125,966                          
Accredited investors shares 165,738                            
Transaction expenses $ 600,000                            
Share price $ 30.75                            
Options to acquire shares                       144,191      
Weighted exercise price $ 10.71                     $ 10.71      
Warrants to purchase shares 4,424                            
Exercise price $ 7.32                            
Expiration date Apr. 22, 2031                            
Net income                 $ (12,512) $ (34,481)   $ (39,693) (36,113)    
Common Stock [Member]                              
Loss Contingencies [Line Items]                              
Accredited investors shares                 165,738   50,370        
Warrants to purchase shares 12,301                            
Exercise price $ 12.05                            
Expiration date Aug. 10, 2030                            
2009 [Member] | Resorbable Bone Hemostat [Member]                              
Loss Contingencies [Line Items]                              
Annual royalty obligation                       $ 201,000      
Royalty percentage                       2.00%      
Precision Healing [Member]                              
Loss Contingencies [Line Items]                              
Cash       $ 10,000,000.0                      
Share price     $ 27.13 $ 27.13                      
Wound Care Solutions Limited [Member]                              
Loss Contingencies [Line Items]                              
Net income               $ 220,000       $ 200,000      
Wound Care Solutions Limited [Member] | 2021 Through 2024 [Member]                              
Loss Contingencies [Line Items]                              
Net income               $ 20,000              
Sub License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Net sales description             On August 27, 2018, the Company entered into an exclusive, world-wide sublicense agreement with CGI Cellerate RX, LLC (“CGI Cellerate RX”) to distribute CellerateRX Surgical and HYCOL products into the surgical and wound care markets. Pursuant to the sublicense agreement, the Company pays royalties of 3-5% of annual collected net sales of CellerateRX Surgical and HYCOL. As amended on January 26, 2021, the term of the sublicense extends through May 2050, with automatic successive year-to-year renewal terms thereafter so long as the Company’s Net Sales (as defined in the sublicense agreement) each year are equal to or in excess of $1,000,000. If the Company’s Net Sales fall below $1,000,000 for any year after the initial expiration date, CGI Cellerate RX will have the right to terminate the sublicense agreement upon written notice                
Annual royalty obligation             $ 400,000                
BIAKOS License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Royalty expense                       $ 60,000 $ 55,000    
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage           2.00%                  
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage           4.00%                  
BIAKOS Agreement [Member]                              
Loss Contingencies [Line Items]                              
Royalty payments           $ 1,000,000                  
BIAKOS Agreement [Member] | Rochal Industries LLC [Member]                              
Loss Contingencies [Line Items]                              
Annual royalty obligation           120,000                  
Royalties payable           10,000                  
Maximum amount of royalty           $ 150,000                  
ABF License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Annual royalty obligation         $ 50,000                    
Maximum amount of royalty         75,000                    
Royalty payments         $ 500,000                    
Royalty annual minimum percentage         10.00%                    
ABF License Agreement [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage         2.00%                    
ABF License Agreement [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage         4.00%                    
Debrider License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Maximum amount of royalty     $ 150,000 $ 150,000                      
Royalty payments     $ 1,000,000                        
Royalty annual minimum percentage     10.00%                        
Cash     $ 600,000 $ 600,000                      
Cash     1,000,000                        
Payments for royalty     $ 1,000                        
Debrider License Agreement [Member] | Subsequent Event [Member]                              
Loss Contingencies [Line Items]                              
Cash                           $ 600,000  
Debrider License Agreement [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage     2.00%                        
Debrider License Agreement [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage     4.00%                        
Royalty Agreement [Member] | 2009 [Member] | Resorbable Bone Hemostat [Member]                              
Loss Contingencies [Line Items]                              
Royalty annual minimum percentage                       8.00%